Author

M. Middlecamp

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. I. Kuehne· 2 shared A. S. Herbert· 2 shared A. Wang· 2 shared C. K. Hjorth· 2 shared J. S. McLellan· 2 shared K. Chandran· 2 shared L. Stuart· 2 shared R. R. Bakken· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. I. Kuehne

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread

F. Pahmeier, S. R. Monticelli, X. Feng, C. K. Hjorth, A. Wang, A. I. Kuehne, R. R. Bakken, T. G. Batchelor, S. E. Lee, M. Middlecamp, L. Stuart, D. M. Abelson, J. S. McLellan, S. B. Biering, A. S. Herbert, , E. Harris

This study identifies GP38 as a viral toxin causing vascular leak and shows that specific GP38-targeting antibodies block this effect in vitro and in vivo.

bioRxiv · May 23, 2024Microbiology

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38

O. S. Shin, S. R. Monticelli, C. K. Hjorth, V. Hornet, M. Doyle, D. Abelson, A. I. Kuehne, A. Wang, R. R. Bakken, A. K. Mishra, M. Middlecamp, E. Champney, L. Stuart, D. P. Maurer, J. Li, , J. S. McLellan

The paper identifies non-neutralizing antibodies from CCHFV survivors that target multiple regions on GP38, showing protective efficacy in rodent models.

bioRxiv · Mar 2, 2024Immunology